Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-06, Stock:ABBV, The news for the past five days is as follows:
2019-02-27: NEWS1: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS2: Big Pharma's Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS3: Big Pharma&apos;s Showdown With Congress Over Drug Pricing: What It Really Means for You.NEWS4: The patent system ‘keeps American drug prices so high’.NEWS5: Senate panel grills pharma CEO over executive bonuses. Calls tie to sales of AbbVie blockbuster drug Humira &apos;problematic&apos;.NEWS6: Senate panel grills pharma CEO over executive bonuses. Calls tie to sales of AbbVie blockbuster drug Humira 'problematic'.NEWS7: Voyager Therapeutics, Inc. (VYGR) Q4 2018 Earnings Conference Call Transcript.NEWS8: Senators Press Drug-Company Executives Over Prices.
2019-02-28: NEWS1: These 10 New Drugs Expected In 2019 Are On The Blockbuster Track.NEWS2: Is now the time to buy Rio Tinto? How does Abbvie look here? The desk answers your questions.NEWS3: 3 Top Stocks With High Dividend Yields.NEWS4: 3 Top Stocks With High Dividend Yields.NEWS5: IYH, ABT, MDT, ABBV: Large Outflows Detected at ETF.NEWS6: IYH, ABT, MDT, ABBV: Large Outflows Detected at ETF.NEWS7: 3 Top Stocks With High Dividend Yields.NEWS8: AbbVie to Present at the Cowen Health Care Conference.NEWS9: 10 Stocks With Safe, Generous Dividends.
2019-03-01: NEWS1: Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers Grill CEOs Over High Drug Prices.NEWS2: AbbVie to Present at the Barclays Global Healthcare Conference.NEWS3: AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI™) for the Treatment of Moderate to Severe Plaque Psoriasis.
2019-03-04: NEWS1: Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today.NEWS2: Here's Why Voyager Therapeutics Stock Rose as Much as 13% Today.NEWS3: Top Research Reports for Intel, AbbVie & United Technologies.NEWS4: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS5: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS6: AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab.NEWS7: This Is Why TG Therapeutics Stock Soared 65.9% in February.NEWS8: This Is Why TG Therapeutics Stock Soared 65.9% in February.
2019-03-05: NEWS1: The Zacks Analyst Blog Highlights: Intel, AbbVie, United Technologies, Simon Property and FirstEnergy.NEWS2: The Zacks Analyst Blog Highlights: Intel, AbbVie, United Technologies, Simon Property and FirstEnergy.NEWS3: The Zacks Analyst Blog Highlights: Intel, AbbVie, United Technologies, Simon Property and FirstEnergy.

Answer: Decrease